Main Article Content

Abstract

RÉSUMÉ
Introduction. La maladie coronaire représente la première cause de décès chez le diabétique. L’objectif de notre travail était de comparer les complications des syndromes coronariens aigus chez les diabétiques et les non diabétiques. Patients et méthodes. Il s’agissait d’une étude de cohorte prospective portant sur les patients hospitalisés au service de cardiologie du CHU-YO pour SCA du 1er janvier 2017 au 31 décembre 2017 avec un suivi clinique et paraclinique de 06 mois de tous les patients soit une durée d’étude totale de 18 mois. Résultats. Cinquante patients porteurs de SCA ont été étudiés dont 23 diabétiques (71,4% de femmes ; âge moyen 59,8 ans, écart-type 9,5 ) et 27 non diabétiques (28.6% de femmes, âge moyen 53,1 ans, écart-type 9,5 16, 8). La symptomatologie douloureuse atypique était significativement plus fréquente chez les diabétiques (35 %) par rapport aux non diabétiques (14 %) (P=0,09) et le délai avant admission était également plus long chez les diabétiques. Les diabétiques présentaient plus de facteurs de risque cardiovasculaires notamment l’HTA, la dyslipidémie et le surpoids. Parmi les patients admis pour SCA ST+, 58,7% étaient non diabétiques contre 41,3% chez les diabétiques (P= 0,6). En ce qui concerne le SCA ST-, il y avait autant de diabétiques que de non diabétiques (50% versus 50%) (P=0,64).). A l’admission, 8% des patients étaient en choc cardiogénique parmi lesquels 75% étaient des non diabétiques et 25% des diabétiques. Au sixième mois du suivi, le taux de létalité était de 26.1% (6/23) chez les diabétiques et de 14.8% (4/27) chez les non diabétiques (p=0.3). Conclusion. Les complications des SCA sont plus fréquentes chez les diabétiques. Pour réduire la morbi-mortalité chez ces derniers, une prise en charge adéquate et un bon contrôle glycémique sont nécessaires.
ABSTRACT
Introduction. Coronary heart disease is the leading cause of death in diabetics. The aim of our work was to compare the complications of acute coronary syndromes in diabetics and non-diabetics. Patients and methods. This was a prospective cohort study of patients hospitalized in the cardiology department of CHU-YO for ACS from January 1, 2017 to December 31, 2017 with 06 months of clinical and paraclinical follow-up of all patients, for a total study duration of 18 months. Results. Fifty patients with ACS were studied, including 23 diabetics (71.4% women; mean age 59.8 years, SD 9.5 ) and 27 non-diabetics (28.6% women, mean age 53.1 years, SD 9.5 16, 8). Atypical pain symptomatology was significantly more frequent in diabetics (35%) than in non-diabetics (14%) (P=0.09), and time to admission was also longer in diabetics. Diabetics had more cardiovascular risk factors, notably hypertension, dyslipidemia and overweight. Among patients admitted for ST+ ACS, 58.7% were non-diabetic versus 41.3% among diabetics (P= 0.6). In the case of ST- ACS, there were as many diabetics as non-diabetics (50% versus 50%) (P=0.64). On admission, 8% of patients were in cardiogenic shock, of whom 75% were non-diabetics and 25% diabetics. At six months' follow-up, the case fatality rate was 26.1% (6/23) in diabetics and 14.8% (4/27) in non-diabetics (p=0.3). Conclusion. Complications of ACS are more frequent in diabetics. To reduce morbidity and mortality in diabetic patients, adequate management and good glycemic control are essential.

Keywords

Diabetes Acute Coronary Syndrome Complications Mortality Cardiovascular Risk Factors Diabète Syndrome coronarien aigu Complications Mortalité Facteurs de risque cardiovasculaire

Article Details

How to Cite
M’baye Salissou SM, Tsague Kengni HN, Amadou D, Maliki Abdoulaye M, Mianroh HL, Lawan H, Samaila A, Ngo Yon LC, Guindo A, Toga A, Oumarou Garba S, Ndobo V, Salifou Lankoande Z, Yameogo NV, & Zabsonre P. (2024). Acute Coronary Syndromes in Diabetics at the Yalgado Ouédraogo University Hospital (Ouagadougou): A Comparative Study: Les Syndromes Coronariens Aigus Chez les Diabétiques au Centre Hospitalier Universitaire Yalgado Ouédraogo (Ouagadougou) : Une Étude Comparative. HEALTH SCIENCES AND DISEASE, 25(10). https://doi.org/10.5281/hsd.v25i10.6069

References

  1. International diabetes federation. Consulté le 20 Jan 2017. IDF Diabetes Atlas 7th Edition, [en ligne]. Disponible : https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/13-diabetes-atlas-seventh-edition.html.
  2. Ministère de la santé publique du Burkina Faso. Consulté le 20 juillet 2024. Enquête STEPS,Burkina,2013,[enligne].Disponible :https://www.who.int/ncds/surveillance/steps/BurkinaFaso_2013_STEP_Report.pdf.
  3. Assman G, Schulte I. Identification of individuals at high risk for myocardial infarction. Atherosclerosis.1994; 110:11-21;
  4. A.Bakhaia, B Collinson. Diabetic patients with acute coronary syndromes in the UK: high risk and under treated. Results from the prospective registry of acute ischaemic syndromes in the UK (PRAIS-UK). International journal of cardiology. 2005 ; 100 :79-75.
  5. Abbas Ali M, Hameed Laftah W. Acute Phase Hyperglycemia among Patients Hospitalized with Acute Coronary Syndrome: Prevalence and Prognostic Significance. Oman medical journal .2011; 26:85-86.
  6. Kraif M, Champennois A, Fournier M et al. Prise en charge préhospitalière des syndromes coronariens aigus ST+ à Marseille. Évaluation prospective. Journal Europeen des Urgences. 2009 juin ; 22, 2suppl7 : SA 33.
  7. Bottorff MB, Nutescu EA, Spinler S. Antiplatelet therapy in patients with unstable angina and non-ST-segment-elevation myocardial infarction: findings from the CRUSADE national quality improvement initiative. Pharmacotherapy. 2007; 27(8):1145-1152.
  8. Ben Salem H1, Ouali S, Hammas S and al. Influence of diabetes mellitus on the prognosis of non-ST-elevation acute coronary Syndromes. Ann Cardiol Angéol .2011 ; 60 :33-35.
  9. Merzouk F, Bendriss L, Khatouri A. Syndrome coronarien aigu et diabète type 2 : étude de 244 cas de l’hôpital militaire Avicenne de Marrakech pour syndrome coronarien aigu (SCA). Diabetes & Metabolism. 2013 Mars; 39 N° S1:A118
  10. Gilles L. Association of Diabetic Status and Glycemic Control With Ischemic and Bleeding Outcomes in Patients With Stable Coronary Artery Disease: The 5‐Year CORONOR Registry. Am Heart Assoc. 2018 May 15 ; 7(10) : 008354.
  11. Vergès B, Avignon A, Bonnet F et al. Consensus statement on the care of the hyperglycaemic/ diabetic patient during and in the immediate follow-up of acute coronary syndrome. Diabetes Metab.2012 ; 38(2) :113-27.
  12. Kosiborod M, Inzucchi SE, Krumholz HM et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation .2008; 117:1018-27;
  13. Turner RC1, Millns H, Neil HA and al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study. BMJ.1998; 16:823-828;
  14. Brieger D, Goodman SG, P. Gabriel Steg PG et al. Acute Coronary Syndromes Without Chest Pain, An Underdiagnosed and Undertreated High-Risk Group. CHEST.2004; 126(2);
  15. Bradley RF, Schonfeld A. Diminished pain in diabetic patients with acute myocardial infarction. Geriatrics.1962 ; 17 : 322–326.
  16. Marc G. Evaluation de la stratégie thérapeutique du syndrome coronarien aigu sans sus-décalage persistant du segment ST au SAMU 54 et aux urgences du CHU de Nancy. Thèse médecine. UNIVERSITE HENRI POINCARE, NANCY 2009 no: 2009NAN11170;
  17. Muataz Fawzi Hussein. Clinical and Angiographic Findings in Diabetic Versus Non Diabetic Iraqi Patients with Ischemic Heart Disease. The Iraqi postgraduate medical journal.2011; 3: 15-19;
  18. Yeh RW, Sidney S, Cjandra M and al. Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction. N Engl J Med .2010; 362:2155-65;
  19. Wallander M, Malmberg K, Norhammar A and al. Oral glucose tolerance test: a reliable tool for early detection of glucose abnormalities in patients with acute myocardial infarction in clinical practice: a report on repeated oral glucose tolerance tests from the GAMI study. Diabetes Care .2008; 31:36-8;
  20. Deedwania O, Kosiborod M, Barrett E et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity and Metabolism. Circulation. 2008; 117:1610-9;
  21. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet .2000; 355:773-8;
  22. Svensson AM, McGuire DK, Abrahamsson P and al. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur J Heart .2005; 26:1255-61;
  23. Norhammar A, Lindbäck J, Rydén L et al. Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA). Improved but still high short-and long-term mortality rates after myocardial in farction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission. Heart Br Card Soc. 2007; 93(12):157-783;
  24. Vergès B, Zeller M, Dentan G et al. Impact of fasting glycemia on short-termprognosis after acute myocardial infarction. J Clin Endocrinol Metab.2007; 92(6):2136–40;
  25. Fazel R, Frang J, Kline E. Prognostic value of elevated biomarkers in diabetic and non-diabetic patients admitted for acute coronary syndromes. Euro Heart J. 2005; 91:388-2;
  26. Maha H. Influence du diabète sur le pronostic des syndromes coronariens aigus. Thèse médecine. Université CADI AYYAD, Marrakech 2015 n°16;
  27. Société francophone du diabétologie. Consulté le 3 Jan 2018. Recommandations SFC/ALFEDIAM sur la prise en charge du patient diabétique vu par le cardiologue. [Publié en Janvier 2004]. Disponible : https://www.sfdiabete.org/mediatheque/kiosque/le-coin-de-la-biblio/recommandations-sfcalfediam-sur-la-prise-en-charge-du

Most read articles by the same author(s)